Browse by category

Laekna and Eli Lilly to develop ActRIIA antibody for muscle-preserving weight loss in obesity

Laekna Therapeutics has entered a clinical collaboration with Eli Lilly to accelerate the development of LAE102, a novel Activin Receptor...

SURMOUNT-5: Zepbound superior to Wegovy in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%

4 days ago

LUCIDITY trial to assess Avexitide in post-bariatric hypoglycaemia patients

4 days ago

Inflatable gastric balloon with controller could help people lose weight

4 days ago

Weekly Digest